Respiratory Physiotherapy and Neurorehabilitation in Patients With Post-covid19 Sequelae.

The objectives are to reduce dyspnoea, increase exertional capacity, increase vital capacity and respiratory muscle strength.

vital capacity and respiratory muscle strength. In addition to increasing the sensibility of smell and taste, observing if there is a relationship between the decrease of these senses with the senses with appetite and whether appetite has normalised in post-SARS-CoV-2 patients. It is a randomised and blinded experimental study with a control group where the sample recruited will be 30 patients, with a range of of 30 patients, with an age range of 19-42 years, where they carried out an assessment of spirometry, modified Borg dyspnoea scales and modified Medical Research Council (MMRC), Singapure (MMRC), Singapore Smell and Taste Questionnaire (SSTQ) and weekly smell and taste questionnaire.

taste questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Pandemic Agnosia COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Nidovirales Infections Pathological Conditions, Signs and Symptoms Perceptual Disorders Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Virus Diseases

Age range

18 year–42 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad Católica de Ávila

Ávila, 05005, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age range between 18 and 42 years.
patients with respiratory sequelae post Covid-19.
patients with smell and taste sequelae post Covid-19.

Exclusion criteria

Under 18 years old.
Over 42 years old.
Patients not diagnosed with Covid-19 (PCR positive).

Treatment and study plan

respiratory treatment

Other

Respiratory treatment based on aerobic exercise and treatment of the musculature to reduce dyspnoea and increase the capacity for exertion, neurorehabilitative treatment focusing on the sense of smell and taste to on the sense of smell and taste to increase sensitivity in post Covid-19 subjects.

Primary outcomes

assessment of spirometry.

Time frame: 1 year

modified Borg dyspnoea scales (0, minimum to 10 maximum rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administered during six-minute walk testing)
smell and taste

Time frame: 1 week

smell and taste questionnaire, maximum score (maximum capacity) 40 points. 0 minimum

Sponsors and collaborators

Lead sponsor

Universidad Católica de Ávila

Other

Registry information

Official study title

Effectiveness of a Physiotherapy Respiratory and Neurorehabilitation Treatment Protocol in Patients With COVID-19.

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Jan 18, 2022
Registry last updated: Jun 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed